NextCure to merge with Avere Therapeutics.
NextCure, Inc. entered into a definitive merger and reorganization agreement with Avere Therapeutics and its subsidiaries on July 14, 2026. This strategic corporate transaction aims to combine their biopharmaceutical pipelines and enhance combined market capabilities.
View filing at SEC.gov →